raloxifene hydrochloride has been researched along with Colonic Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brewer, M; Bryant, T; Janakiram, NB; Lightfoot, S; Mohammed, A; Rao, CV; Steele, VE; Zhang, Y | 1 |
Janakiram, NB; Rao, CV; Steele, VE | 1 |
Achilefu, S; Akers, W; Gu, Y; Li, H; Ma, Y; Tian, J; Tu, Z | 1 |
3 other study(ies) available for raloxifene hydrochloride and Colonic Neoplasms
Article | Year |
---|---|
Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Animals; Anticarcinogenic Agents; Apoptosis; Azoxymethane; Bexarotene; Biomarkers, Tumor; Blotting, Western; Colonic Neoplasms; Drug Therapy, Combination; Estrogen Antagonists; Estrogen Receptor beta; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Grading; Raloxifene Hydrochloride; Rats; Rats, Inbred F344; Real-Time Polymerase Chain Reaction; Retinoid X Receptors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrahydronaphthalenes; Tissue Array Analysis; Tumor Cells, Cultured | 2013 |
Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.
Topics: Animals; Antineoplastic Agents; Azoxymethane; Blotting, Western; Carcinogens; Cell Line, Tumor; Chemoprevention; Colonic Neoplasms; Estrogen Receptor beta; Humans; Immunohistochemistry; Intestinal Mucosa; Male; Maximum Tolerated Dose; Raloxifene Hydrochloride; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Estrogen receptor β potentiates the antiproliferative effect of raloxifene and affects the cell migration and invasion in HCT-116 colon cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colon; Colonic Neoplasms; Dependovirus; Estrogen Receptor beta; Genetic Vectors; HCT116 Cells; Humans; Mice; Mice, Nude; Raloxifene Hydrochloride; Transfection; Xenograft Model Antitumor Assays | 2012 |